Lupus Eritematosus Sistemik pada Pria

Harry Andrean, Raveinal Raveinal

Abstract


Introduction: Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by presence of nucleus autoantibody and affected multiple organ. Systemic lupus erythematosus is more common in women than men with ratio 2:1 to 15:1. Men with SLE often have a more aggressive clinical course, lead to a poorer prognosis compared with women with SLE. Case Report: A man, 29 years old came to hospital with main complain joint pain increased since 1 week ago, accompanied with red spot on face, trunk, hands, foot, and back, hair loss, swollen leg, mouth ulcer, and fatique. Malar rash and discoid rash were identified from physical examination. From laboratorium, ANA profile was positive for RNP/Sm, Sm, dsDNA, and histone. Skin biopsy showed a lupus discoid. Conclusion: The patient was treated with pulse-dose methylprednisolone for 3 days and showed a good response clinically.


Keywords


Clinical Science

Full Text:

PDF

References


Lockshin MD. Sex differences in autoimmune disease. Lupus. 2006;15(11):753–6.

Nusbaum JS, Mirza I, Shum J, Freilich RW, Cohen RE, Pillinger MH, et al. Sex Differences in Systemic Lupus Erythematosus: Epidemiology, Clinical Considerations, and Disease Pathogenesis. Mayo Clin Proc [Internet]. 2020;95(2):384–94. Available from: https://doi.org/10.1016/j.mayocp.2019.09.012

Ramírez Sepúlveda JI, Bolin K, Mofors J, Leonard D, Svenungsson E, Jönsen A, et al. Sex differences in clinical presentation of systemic lupus erythematosus. Biol Sex Differ. 2019;10(1):1–7.

Roy JS, Das PP, Datta A. SLE in pregnancy. Chinese Med J. 1981;28(3):247.

Font J, Cervera R, Navarro M, Pallares L, Lopez-Soto A, Vivancos J, et al. Systemic lupus erythematosus in men: Clinical and immunological characteristics. Ann Rheum Dis. 1992;51(9):1050–2.

Suarjana, IN. Imunopatogenesis Lupus Eritematosus Sistemik. Buku Ajar Ilmu Penyakit Dalam Edisi 6. Interna Publishing.2014

Lech M, Anders HJ. The pathogenesis of lupus nephritis. J Am Soc Nephrol. 2013;24(9):1357–66.

Liu Y, Anders HJ. Lupus nephritis: From pathogenesis to targets for biologic treatment. Nephron - Clin Pract. 2014;128:224–31.

Perhimpunan Reumatologi Indonesia. Rekomendasi Perhimpunan Reumatologi Indonesia Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik.2019.

Bertsias GK, Pamfil C, Fanouriakis A, Boumpas DT. Diagnostic criteria for systemic lupus erythematosus: Has the time come? Nat Rev Rheumatol [Internet]. 2013;9(11):687–94. Available from: http://dx.doi.org/10.1038/nrrheum.2013.103

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(9):1400–12.

Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, et al. 2019 Update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–45.

Porta S, Danza A, Arias Saavedra M, Carlomagno A, Goizueta MC, Vivero F, et al. Glucocorticoids in Systemic Lupus Erythematosus. Ten Questions and Some Issues. J Clin Med. 2020;9(9):2709.

Mok CC. Understanding lupus nephritis: Diagnosis, management, and treatment options. Int J Womens Health. 2012;4(1):213–22.

Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):825–35.

Bajaj DR, Devrajani BR, Matlani BL. Discoid lupus erythematosus: A profile. J Coll Physicians Surg Pakistan. 2010;20(6):361–4.

Insawang M, Kulthanan K, Chularojanamontri L, Tuchinda P. Discoid lupus erythematosus: Description of 130 cases and review of their natural history and clinical course. J Clin Immunol Immunopathol Res. 2010;2(1):1–8.

Uribe AG, Vilá LM, McGwin G, Sanchez ML, Reveille JD, Alarcón GS. The Systemic Lupus Activity Measure-Revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a Modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol. 2004;31(10):1934–40.

Chaiamnuay S, Lomaratana V, Sumransurp S, Phukongchai S, Narongroeknawin P, Asavatanabodee P. Health-related quality of life and disease severity of SLE patients in Phramongkutklao Hospital. J Med Assoc Thai. 2010;93 Suppl 6(November 2010).

Conti F, Ceccarelli F, Perricone C, Massaro L, Marocchi E, Miranda F, et al. Systemic Lupus Erythematosus with and without Anti-dsDNA Antibodies: Analysis from a Large Monocentric Cohort. Mediators Inflamm. 2015;2015(June):328078.




DOI: https://doi.org/10.33854/heme.v3i2.664

Refbacks

  • There are currently no refbacks.


Creative Commons License   Health and Medical Journal This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.